Ensign Peak Advisors’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-139,196
| Closed | -$564K | – | 1773 |
|
|
2023
Q4 | $564K | Hold |
139,196
| – | – | ﹤0.01% | 1635 |
|
|
2023
Q3 | $374K | Sell |
139,196
-3,402
| -2% | -$9.15K | ﹤0.01% | 1655 |
|
|
2023
Q2 | $1.33M | Hold |
142,598
| – | – | ﹤0.01% | 1043 |
|
|
2023
Q1 | $1.27M | Hold |
142,598
| – | – | ﹤0.01% | 1061 |
|
|
2022
Q4 | $710K | Hold |
142,598
| – | – | ﹤0.01% | 1441 |
|
|
2022
Q3 | $827K | Hold |
142,598
| – | – | ﹤0.01% | 1177 |
|
|
2022
Q2 | $788K | Sell |
142,598
-107,402
| -43% | -$594K | ﹤0.01% | 1246 |
|
|
2022
Q1 | $2.88M | Hold |
250,000
| – | – | 0.01% | 742 |
|
|
2021
Q4 | $3.17M | Buy |
+250,000
| New | +$3.17M | 0.01% | 805 |
|